Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

• A. Omega Fatty acids and Brain: An overview1. Essentiality of Omega‐3 Polyunsaturated Fatty Acids for Mammalian Brain Development: A Translational Perspective2. Thinking in polyunsaturated fatty acids, phospholipids and the brain3. The Impact of Omega-3 Fatty Acids on Quality of Life4. The Balance Between n-6 and n-3 and its Relation to Executive Function5. Arachidonic Acid, Docosahexaenoic Acid, and EthanolB. Omega fatty acids: Brain and neurological development6. Prenatal n-3 long-chain polyunsaturated fatty acids and children’s executive functions7. Omega-3 and Omega-6 fatty acid metabolism: Modeling growth and disease using Caenorhabditis elegans8. Fatty acids and the hippocampus9. Energy metabolism of neural cells under the control of phospholipases A2 and docosahexaenoic acid10. Omega-3 and Cognition in Children with Malnutrition11. Neuroprotective effects of melatonin and omega-3 on the central nervous system exposed to electromagnetic fields in the pre- and postnatal periods12. Maternal omega 3 status: effects of cross-fostering on offspring brain lipids and hippocampal neurogenesis13. Linking omega-3 fatty acids and depression14. Omega 3 Fatty Acids and the Cardiovascular SystemC. Diet and Brain disease treatment and Prevention15. Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s disease16. N-3 long chain PUFA-containing phospholipids and neuroprotection17. Omega-3 Polyunsaturated Fatty Acid Supplementation as a Potential Protective Factor or Treatment for Neurodegenerative Diseases18. Neurobiological meaning of Omega-3 Fatty Acids and their potential role in the treatment of schizophrenia19. Neurodevelopmental and behavioral effects of variations in Omega-3 Polyunsaturated Fatty Acids levels in vulnerable populationsD. Nutrients and the Brain20. Omega-3 fatty acids and cognitive behavior 21. Link between sugar intake and fatty acid metabolism in brain22. N-3 and -6 fatty acids in fish: a focus on non-marine species23. Aspartame Induced Neurodegeneration Versus Omega 3 Alleviation 24. DHA-enriched formulations as a promising strategy for the treatment of hypoxic/ischemic brain injury25. Alpha-linolenic acid and dementia in epidemiological studies26. DHA a Key Supplement For Neurologic Health- An Insight27. Obesity, Cognitive Functioning, and Dementia: A Lifespan Perspective28. Fatty acids and brain health29. Epigenetic effects of omega-3 fatty acids on neurons and astrocytes during brain development and senescence

Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

• A. Omega Fatty acids and Brain: An overview1. Essentiality of Omega‐3 Polyunsaturated Fatty Acids for Mammalian Brain Development: A Translational Perspective2. Thinking in polyunsaturated fatty acids, phospholipids and the brain3. The Impact of Omega-3 Fatty Acids on Quality of Life4. The Balance Between n-6 and n-3 and its Relation to Executive Function5. Arachidonic Acid, Docosahexaenoic Acid, and EthanolB. Omega fatty acids: Brain and neurological development6. Prenatal n-3 long-chain polyunsaturated fatty acids and children’s executive functions7. Omega-3 and Omega-6 fatty acid metabolism: Modeling growth and disease using Caenorhabditis elegans8. Fatty acids and the hippocampus9. Energy metabolism of neural cells under the control of phospholipases A2 and docosahexaenoic acid10. Omega-3 and Cognition in Children with Malnutrition11. Neuroprotective effects of melatonin and omega-3 on the central nervous system exposed to electromagnetic fields in the pre- and postnatal periods12. Maternal omega 3 status: effects of cross-fostering on offspring brain lipids and hippocampal neurogenesis13. Linking omega-3 fatty acids and depression14. Omega 3 Fatty Acids and the Cardiovascular SystemC. Diet and Brain disease treatment and Prevention15. Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s disease16. N-3 long chain PUFA-containing phospholipids and neuroprotection17. Omega-3 Polyunsaturated Fatty Acid Supplementation as a Potential Protective Factor or Treatment for Neurodegenerative Diseases18. Neurobiological meaning of Omega-3 Fatty Acids and their potential role in the treatment of schizophrenia19. Neurodevelopmental and behavioral effects of variations in Omega-3 Polyunsaturated Fatty Acids levels in vulnerable populationsD. Nutrients and the Brain20. Omega-3 fatty acids and cognitive behavior 21. Link between sugar intake and fatty acid metabolism in brain22. N-3 and -6 fatty acids in fish: a focus on non-marine species23. Aspartame Induced Neurodegeneration Versus Omega 3 Alleviation 24. DHA-enriched formulations as a promising strategy for the treatment of hypoxic/ischemic brain injury25. Alpha-linolenic acid and dementia in epidemiological studies26. DHA a Key Supplement For Neurologic Health- An Insight27. Obesity, Cognitive Functioning, and Dementia: A Lifespan Perspective28. Fatty acids and brain health29. Epigenetic effects of omega-3 fatty acids on neurons and astrocytes during brain development and senescence

Ronald Ross Watson, PhD, is Professor of Health Promotion Sciences at the University of Arizona, Mel and Enid Zuckerman College of Public Health. Dr. Watson began his research in public health at the Harvard School of Public Health as a Fellow in 1971 doing field work on vaccines in Saudi Arabia. He has done clinical studies in Colombia, Iran, Egypt, Saudi Arabia and the United States which provides a broad international view of public health. He has served in the military reserve hospital for 17 years with extensive training in medical responses to disasters as the chief biochemistry officer of a general hospital, retiring as a Lt. Colonel. He is a distinguished member of several national and international nutrition, immunology, and cancer societies. Dr. Watson’s career has involved studying many lifestyle aspects for their uses in health promotion. He has edited over 100 biomedical reference books and 450 papers and chapters. His teaching and research focuses on alcohol, tobacco, and drugs of abuse in heart function and disease in mouse models. Victor R. Preedy BSc, PhD, DSc, FRSB, FRSPH, FRSC, FRCPath graduated with an Honours Degree in Biology and Physiology with Pharmacology. After gaining his University of London PhD, he received his Membership of the Royal College of Pathologists. He was later awarded his second doctorate (DSc), for his contribution to protein metabolism in health and disease. He is Professor of Clinical Biochemistry (Hon) at King’s College Hospital and Emeritus Professor of Nutritional Biochemistry at King’s College London. He has Honorary Professorships at the University of Hull, and the University of Suffolk. Professor Preedy was the Founding Director and then long-term Director of the Genomics Centre at King’s College London from 2006 to 2020. Professor Preedy has been awarded fellowships of the Royal Society of Biology, the Royal College of Pathologists, the Royal Society for the Promotion of Health, the Royal Institute of Public Health, the Royal Society for Public Health, the Royal Society of Chemistry and the Royal Society of Medicine. He carried out research when attached to the National Heart Hospital (part of Imperial College London), The School of Pharmacy (now part of University College London) and the MRC Centre at Northwick Park Hospital. He has collaborated with international research groups in Finland, Japan, Australia, USA, and Germany. To his credit, Professor Preedy has published over 750 articles, which includes peer-reviewed manuscripts based on original research, abstracts and symposium presentations, reviews and edited books.

• A. Omega Fatty acids and Brain: An overview1. Essentiality of Omega‐3 Polyunsaturated Fatty Acids for Mammalian Brain Development: A Translational Perspective2. Thinking in polyunsaturated fatty acids, phospholipids and the brain3. The Impact of Omega-3 Fatty Acids on Quality of Life4. The Balance Between n-6 and n-3 and its Relation to Executive Function5. Arachidonic Acid, Docosahexaenoic Acid, and EthanolB. Omega fatty acids: Brain and neurological development6. Prenatal n-3 long-chain polyunsaturated fatty acids and children’s executive functions7. Omega-3 and Omega-6 fatty acid metabolism: Modeling growth and disease using Caenorhabditis elegans8. Fatty acids and the hippocampus9. Energy metabolism of neural cells under the control of phospholipases A2 and docosahexaenoic acid10. Omega-3 and Cognition in Children with Malnutrition11. Neuroprotective effects of melatonin and omega-3 on the central nervous system exposed to electromagnetic fields in the pre- and postnatal periods12. Maternal omega 3 status: effects of cross-fostering on offspring brain lipids and hippocampal neurogenesis13. Linking omega-3 fatty acids and depression14. Omega 3 Fatty Acids and the Cardiovascular SystemC. Diet and Brain disease treatment and Prevention15. Dietary Strategies and Supplements for the Prevention of Cognitive Decline and Alzheimer’s disease16. N-3 long chain PUFA-containing phospholipids and neuroprotection17. Omega-3 Polyunsaturated Fatty Acid Supplementation as a Potential Protective Factor or Treatment for Neurodegenerative Diseases18. Neurobiological meaning of Omega-3 Fatty Acids and their potential role in the treatment of schizophrenia19. Neurodevelopmental and behavioral effects of variations in Omega-3 Polyunsaturated Fatty Acids levels in vulnerable populationsD. Nutrients and the Brain20. Omega-3 fatty acids and cognitive behavior 21. Link between sugar intake and fatty acid metabolism in brain22. N-3 and -6 fatty acids in fish: a focus on non-marine species23. Aspartame Induced Neurodegeneration Versus Omega 3 Alleviation 24. DHA-enriched formulations as a promising strategy for the treatment of hypoxic/ischemic brain injury25. Alpha-linolenic acid and dementia in epidemiological studies26. DHA a Key Supplement For Neurologic Health- An Insight27. Obesity, Cognitive Functioning, and Dementia: A Lifespan Perspective28. Fatty acids and brain health29. Epigenetic effects of omega-3 fatty acids on neurons and astrocytes during brain development and senescence